Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Year End Trading Update

14 Nov 2017 15:45

RNS Number : 4915W
IDOX PLC
14 November 2017
 

Idox plc

("Idox", the "Company" or the "Group")

Year End Trading Update

Idox plc (AIM: IDOX), a leading supplier of specialist information management solutions and services, today provides an update on trading for its financial year ended 31 October 2017.

 

Overview

Idox continued to deliver on its strategy during the year and has grown both revenues and profits. The Company has been successful in winning several important contracts to further its focus on becoming a leading international supplier of software, services, managed services and content to the wide public sector in the UK and abroad. Due to customer disruption in the wake of June's General Election, sign-off on some contract wins, especially within health and transport have been delayed into the new financial year, resulting in an impact to 2017 profit expectations. Due to this timing impact the board now expects EBITDA for the year of about £23m, compared with £21.5m in 2016. The Board does expect completion / implementation of the contracts affected in the weeks ahead which means the Company starts 2018 with strong momentum.

In all other respects the business has made good progress in the implementation of its strategy. Public Sector and Digital Divisions have seen further adoption of our new digital solutions and we have continued to see market consolidation on our core back office products, with contracts amounting to £3.5m being awarded in the final quarter of the year. In addition, the company has been awarded the contract to deliver electronic counting of elections in Malta with an initial value of £2.1m.

 

Acquisitions

The integration of Halarose, the supplier of electoral back office software and services to UK local authorities, which Idox acquired in August is progressing well. Halarose helps create a larger, more effective and focused Idox Elections division which will increase market share through cross-selling initiatives to new and existing customers in the UK and Europe.

6PM, the healthcare solutions business acquired in January, has now been fully integrated and has been awarded contracts for 5 new NHS trusts with an order value in excess of £2.8m that we expect to be delivered in the first half of the new financial year.

 

Financial position

Group net debt ended the year at £32.7m compared with £25.1m as at 31 October 2016 and £28.2m as at 30 April 2017. The debt figure reflects acquisitions, including 6PM, and the upfront costs of the delayed contract wins.

 

Outlook

The Board remains confident that the Group is well positioned in its markets and carries excellent momentum into 2018. The Group's focus on helping public sector customers improve efficiency and effectiveness through digital transformation continues to provide considerable growth opportunities. The large proportion of annual revenue from recurring and repeating revenues and a solid order book and pipeline underpins the Group's prospects.

 

Notice of Final Results

The Board intends to report the Group's final results on 20 December 2017.

 

Andrew Riley, Chief Executive of Idox, said:

"Overall Idox has made excellent progress with its strategy of organic and acquisitive growth and our products and services continue to gain traction within our markets.

"The timing of completion of some contracts which has spilled into the new financial year gives us a strong start to 2018, we continue to keep tight control of costs and we are encouraged by the opportunities for the year ahead."

 

This announcement is released by Idox plc and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR"), encompassing information relating to the trading update described herein, and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of the Company by Andrew Riley, Chief Executive Officer.

 

 

Enquiries:

Idox plc +44 (0) 870 333 7101

Laurence Vaughan, Non-Executive Chairman

Andrew Riley, Chief Executive

Jane Mackie, Chief Financial Officer

 

N+1 Singer (NOMAD and Broker) +44 (0) 20 7496 3000

Shaun Dobson

Liz Yong

 

MHP (Financial PR) +44 (0) 20 3128 8100

Reg Hoare

Andrew Leach

Charlie Barker

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUSSVRBUAAAAA
Date   Source Headline
21st Feb 20227:00 amRNSDirectorate Change
11th Feb 20228:46 amRNSGrant of Options
27th Jan 20227:40 amRNSProgressive publishes new research
27th Jan 20227:00 amRNSFinal Results
12th Jan 20227:00 amRNSNotice of Final Results
9th Dec 20219:50 amRNSIdox hosts company event focused on sustainability
25th Nov 20217:00 amRNSExercise of Share Options & Total Voting Rights
16th Nov 20217:00 amRNSYear End Trading Update
7th Oct 20218:08 amRNSHolding(s) in Company
5th Oct 20217:00 amRNSAcquisition
1st Oct 202111:25 amRNSExercise of Share Options & Total Voting Rights
9th Aug 20217:00 amRNSAcquisition
23rd Jul 20212:01 pmRNSHolding(s) in Company
19th Jul 20211:47 pmRNSHolding(s) in Company
1st Jul 20217:00 amRNSExercise of Share Options & Total Voting Rights
15th Jun 20217:00 amRNSHalf-year Report
7th Jun 20217:00 amRNSAcquisition
2nd Jun 20217:00 amRNSExercise of Share Options & Total Voting Rights
24th May 202111:40 amRNSInvestor presentation
20th May 20217:00 amRNSFY21 H1 Trading Update
23rd Apr 20214:00 pmRNSExercise of Share Options & Total Voting Rights
15th Apr 20211:41 pmRNSGrant of Options
13th Apr 20217:00 amRNSExercise of Share Options & Total Voting Rights
12th Apr 20219:40 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSFY21 Q1 Trading Update
22nd Mar 20212:46 pmRNSForm 8.3 - IDOX PLC
19th Mar 20219:07 amRNSForm 8.5 (EPT/RI) IDOX Plc
19th Mar 20217:01 amRNSDisposal of Idox Grants Consultancy business
19th Mar 20217:00 amRNSStatement regarding Dye & Durham’s withdrawal
18th Mar 20211:11 pmRNSResult of AGM
18th Mar 20218:34 amRNSForm 8.5 (EPT/RI) IDOX Plc
17th Mar 202110:51 amGNWForm 8.3 - IDOX PLC
17th Mar 20217:34 amRNSForm 8.5 (EPT/RI) IDOX Plc
16th Mar 20211:08 pmRNSForm 8.3 Disclosure
16th Mar 202112:00 pmRNSForm 8.5 (EPT/RI) IDOX Plc
16th Mar 20219:54 amGNWForm 8.3 - Idox plc
15th Mar 20218:27 amRNSForm 8.5 (EPT/RI) IDOX Plc
15th Mar 20217:00 amRNSTotal Voting Ritghts & Rule 2.9 Announcement
12th Mar 202112:03 pmGNWForm 8.3 - [IDOX plc - 11-03-2021] - (CGWL)
12th Mar 20218:57 amRNSForm 8.5 (EPT/RI) IDOX Plc
12th Mar 20217:00 amRNSDisposal of Idox Compliance
11th Mar 20212:17 pmRNSForm 8.3 Disclosure
11th Mar 202111:38 amGNWForm 8.3 - [IDOX plc - 10-03-2021] - (CGWL)
11th Mar 20218:21 amRNSForm 8.5 (EPT/RI) IDOX Plc
10th Mar 202111:54 amGNWForm 8.3 - [IDOX plc - 09-03-2021] - (CGWL)
10th Mar 20219:46 amRNSForm 8.5 (EPT/RI)
10th Mar 20219:22 amRNSForm 8.5 (EPT/RI) IDOX Plc
9th Mar 202111:44 amGNWForm 8.3 - [IDOX plc - 08-03-2021] - (CGWL)
9th Mar 20218:44 amRNSForm 8.5 (EPT/RI) IDOX Plc
8th Mar 20214:34 pmRNSForm 8.3 - IDOX PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.